These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1810736)

  • 21. No proof of HTLV-I/II in intravenous drug abusers with a high rate of HIV-1 infection in central Thailand.
    Saguanwongse S; Muangpom A; Ruchusatsawat N; Wongcheree S; Warachit P; Miyamura K; Yamazaki S; Honda M
    Microbiol Immunol; 1996; 40(9):639-44. PubMed ID: 8908608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infection with human immunodeficiency viruses and human T-cell lymphotropic viruses in the same individuals in Nigeria.
    Olaleye OD; Ekweozor CC
    Rev Roum Virol; 1993; 44(3-4):233-6. PubMed ID: 7826875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The emerging role of HTLV-I/II and HIV-1 among intravenous drug users in Detroit.
    Ognjan AF; Lewandowski CA; Belian BT; Burczak J; Markowitz N; Lee H; Saravolatz LD
    Henry Ford Hosp Med J; 1992; 40(1-2):131-5. PubMed ID: 1428966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV Study.
    Telzak EE; Hershow R; Kalish LA; Hardy WD; Zuckerman E; Levine A; Delapenha R; DeHovitz J; Greenblatt RM; Anastos K
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):513-8. PubMed ID: 9859966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HIV-2 and HTLV-I/II infections in Spain].
    Toro C; Rodés B; Aguilera A; Caballero E; Benito R; Bassani S; Rodríguez C; Tuset C; Ortiz de Lejarazu R; Eirós J; García J; Calderón E; Capote FJ; Vallejo A; Gutiérrez M; Soriano V;
    Enferm Infecc Microbiol Clin; 2004 Mar; 22(3):177-82. PubMed ID: 14987538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. The HTLV European Research Network.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Sep; 13(1):68-77. PubMed ID: 8797688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HTLV-II among Italian intravenous drug users and hemophiliacs.
    Zanetti AR; Zehender G; Tanzi E; Galli C; Rezza G; Cargnel A; Boschini A; Mari D; Pizzocolo G; Mazzotta F
    Eur J Epidemiol; 1992 Sep; 8(5):702-7. PubMed ID: 1426170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases.
    Khabbaz RF; Onorato IM; Cannon RO; Hartley TM; Roberts B; Hosein B; Kaplan JE
    N Engl J Med; 1992 Feb; 326(6):375-80. PubMed ID: 1729620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current epidemiological status of HIV-2 and HTLV-1 infection in Spain.
    de Mendoza C; Ramos JM; Caballero E; Soriano V;
    Med Clin (Barc); 2021 Mar; 156(6):290-296. PubMed ID: 32798034
    [No Abstract]   [Full Text] [Related]  

  • 30. Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans.
    Wiktor SZ; Cannon RO; Atkinson WL; Lutz B; Hook EW; Blattner WA; Quinn TC
    J Infect Dis; 1992 May; 165(5):920-4. PubMed ID: 1569344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of HTLV-I/II antibodies in HIV seropositive and HIV seronegative STD patients in Vellore region in southern India.
    Babu PG; Ishida T; Nesadoss J; John TJ
    Scand J Infect Dis; 1995; 27(2):105-8. PubMed ID: 7660071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London.
    Brennan M; Runganga J; Barbara JA; Contreras M; Tedder RS; Garson JA; Tuke PW; Mortimer PP; McAlpine L; Tosswill JH
    BMJ; 1993 Nov; 307(6914):1235-9. PubMed ID: 8281054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence of human T-lymphotropic virus type I or II in sexually transmitted disease clinic patients in the USA.
    Khabbaz RF; Douglas JM; Judson FN; Spiegel RA; St Louis ME; Whittington W; Hartley TM; Lairmore M; Kaplan JE
    J Infect Dis; 1990 Jul; 162(1):241-4. PubMed ID: 2192006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of HTLV-1/2 infection among HCV-infected patients with no HIV-1/2 infection in Spain.
    Vallejo A; Loza E; Mateos ML
    J Clin Virol; 2015 Mar; 64():72-3. PubMed ID: 25728082
    [No Abstract]   [Full Text] [Related]  

  • 35. [HTLV-I AND HTLV-II in Spain].
    An Med Interna; 1995 Jun; 12(6):299-306. PubMed ID: 7548650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type-specific immune response to human T cell lymphotropic virus (HTLV) type I and type II infections in Nigeria.
    Olaleye DO; Bernstein L; Sheng Z; Ekweozor CC; Li XY; Sullivan-Halley J; Rasheed S
    Am J Trop Med Hyg; 1994 Apr; 50(4):479-86. PubMed ID: 8166356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human retroviruses in Amerindians of Colombia: high prevalence of human T cell lymphotropic virus type II infection among the Tunebo Indians.
    Duenas-Barajas E; Bernal JE; Vaught DR; Nerurkar VR; Sarmiento P; Yanagihara R; Gajdusek DC
    Am J Trop Med Hyg; 1993 Dec; 49(6):657-63. PubMed ID: 8279632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological patterns and temporal trends of HTLV-1/2 infection in high-risk populations attending Public Health Units in São Paulo, Brazil.
    Jacob F; Santos-Fortuna E; Azevedo RS; Caterino-de-Araujo A
    J Clin Virol; 2008 Jun; 42(2):149-55. PubMed ID: 18346935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospital-based surveillance for HTLV-1/2 infections in Spain.
    Toro C; Aguilera A; Caballero E; Tuset C; Alvarez P; García-Campello M; Rodríguez-Iglesias M; de Lejarazu RO; Eiros J; Rodriguez C; del Romero J; Benito R; Calderón E; Santana O; Amor A; Gómez-Hernando C; García J; Soriano V
    AIDS Res Hum Retroviruses; 2007 Sep; 23(9):1075-7. PubMed ID: 17919100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain.
    Treviño A; Aguilera A; Caballero E; Benito R; Parra P; Eiros JM; Hernandez A; Calderón E; Rodríguez M; Torres A; García J; Ramos JM; Roc L; Marcaida G; Rodríguez C; Trigo M; Gomez C; de Lejarazu RO; de Mendoza C; Soriano V;
    Virol J; 2012 Mar; 9():71. PubMed ID: 22444832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.